Head-to-head · Cost-Efficiency Index
WellMedr vs Injectco
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WellMedr
Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.
Visit WellMedrInjectco
Cost-first shoppers who want texas-area patients comfortable prepaying a lump sum for a 6-8 month supply without the page specifying which drug they're buying.
Visit InjectcoThe verdict
Injectco takes it, leading the Cost-Efficiency Index 56 to 54. Injectco is a Dallas-area medspa network (locations across Cleburne, Colleyville, Plano, Waxahachie, Argyle, Woodlands, Fort Worth, Dallas, and Austin) offering compounded GLP-1 as a single bulk package: $1,249 (from $1,599) for a 6-8 month supply, payable as roughly $156/month. WellMedr still earns a C — Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Injectco.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WellMedr | Injectco |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 56/100 |
| Semaglutide / mo | Not disclosed — 12-month lock-in rate only | $156/mo (starting dose, prepay plan, compounded) |
| Tirzepatide / mo | Not disclosed — "starting at" only, no standing rate | $156/mo (starting dose, prepay plan, compounded) |
| Semaglutide / yr (modeled) | — | $1,872 |
| Tirzepatide / yr (modeled) | — | $1,872 |
| Coverage | 50 states claimed, no list published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #319 | #325 |
WellMedr
54/100Where the value is
- The compounding caveat sits ON the pricing page beside the plan cards rather than in a footer: "Compounded medications are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy," printed with explicit thyroid C-cell tumor and medullary thyroid carcinoma warnings
- Both halves of the supply chain are named and checkable — OpenLoop Healthcare Partners, PC and its state professional corporations as the prescribing group in the telehealth consent, and Mycelium Pharmacy as the fulfillment pharmacy in the HIPAA notice
- The tirzepatide card states "Same price regardless of dosage," so titrating up does not re-price that plan — the single most common way a cheap first month becomes an expensive fourth one
The tradeoffs
- No standing month-to-month rate is published for either compounded drug. The cards say "Starting At $59 a month" and "Starting At $99 a month," the banner on the same page ties the $59 to "12/month Plans — For Life," and both buttons hand off to an intake app that will not quote anything without a plan already chosen
- Two live landers advertise two different lifetime rates for the same program — /pages/get-started-weight-loss offers "$200 OFF Every Month, or $59/mo on 12/month Plans" while /pages/weightloss-with-wellmedr offers "$150 OFF Every Month, or $88/mo on 12/month Plans," and that second page then shows only the $1,399 and $1,599 brand cards
Injectco
56/100Where the value is
- Bulk pricing ($1,249 for 6-8 months) works out cheaper per month than many monthly-billed competitors, if the buyer needs that long a supply
- Interest-free-style payment plan breaks the lump sum into ~$156 installments
- HSA/FSA eligible with itemized receipts for reimbursement
The tradeoffs
- The page never specifies whether the price is for semaglutide or tirzepatide — a shopper cannot tell which medication $1,249 buys them
- '$156/month' is a prepaid-order installment, not a true recurring subscription price — the actual commitment is $1,249 up front for 6-8 months
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.